Poliovirus-sensitive transgenic mice were produced by introducing the human gene encoding cellular receptors for poliovirus into the mouse genome. Expression of the receptor mRNAs in tissues of the transgenic mice was analyzed by using RNA blot hybridization and the polymerase chain reaction. The human gene is expressed in many tissues of the transgenic micejust as in tissues of humans. The transgenic mice are susceptible to all three poliovirus serotypes, and the mice inoculated with poliovirus show clinical symptoms similar to those observed in humans and monkeys. Rabbit antipoliovirus serum detects the antigens mainly in motor neurons in the anterior horn of the spinal cord and in nerve cells in the medulla oblongata and pons of the paralyzed transgenic mice. Therefore, cell types sensitive to poliovirus in the central nervous system of the transgenic mice appear to be identical to those of humans and monkeys. Furthermore, many more doses of oral poliovirus vaccine strains than ofthe virulent strains are required to cause paralysis in the transgenic mice. This may reflect the observation that the virulent strain multiplies more efficiently in the central nervous system than the attenuated strain. Thus, the transgenic mice may become an excellent new animal model to study molecular mechanisms of pathogenesis of poliovirus and to assess oral poliovirus vaccines.
. Of these, the membrane-bound PVRa and PVR8, which correspond to H20A and H20B (4) , are functional receptor molecules. Although it has been proved that PVRs are members of the immunoglobulin superfamily (4), physiological functions of these molecules are totally unknown at present.
Mouse L cells are not permissive for poliovirus infection. However, mouse L cell transformants carrying the human PVR gene (assigned the symbol PVS for poliovirus sensitivity) (5) or the PVR cDNA (4, 5) are permissive for the infection ofall three serotypes ofpoliovirus. This observation confirms the previous notion that all three serotypes of poliovirus compete for the same cellular receptor (3) . This result also indicates that mouse cells have cellular factors supporting poliovirus replication except for the receptor. This in turn led to the possibility for producing poliovirussensitive transgenic mice by introducing the human PVR gene into the mouse genome.
Here we describe the introduction of the human poliovirus receptor gene into the mouse genome and the characterization of the transgenic mice in regard to the expression of the human gene in mouse tissues and the permissiveness for poliovirus infection.
Poliovirus, the causative agent of poliomyelitis, is a human enterovirus that belongs to the Picornaviridae family and is classified into three stable serotypes (type 1, type 2, and type 3). Poliovirus infection is initiated by ingestion of virus followed by its primary multiplication in the oropharyngeal and intestinal mucosa. Extensive viral multiplication occurs in the tonsils and Peyer's patches of the ileum. From these sites, virus drains into deep cervical and mesenteric lymph nodes, and then into the blood. Although many tissues are exposed to the virus during the viremic phase, sites of poliovirus replication are limited to certain tissues. Paralytic poliomyelitis occurs as a result of destruction of motor neurons in the central nervous system (CNS). Poliovirus infects only primates and cannot infect mice except for type 2 virulent strains. Therefore, monkeys have to be used to investigate the pathogenesis ofpoliovirus as well as to test the quality of live attenuated poliovirus vaccines.
The characteristic species specificity and tissue tropism of poliovirus are considered to be primarily determined by a specific cell-surface receptor (1) (2) (3) . Recently, the genomic and complementary DNAs for human poliovirus receptors (PVRs) were isolated from HeLa S3 cells (4, 5) . In addition, four mRNA isoforms for human PVRs, that is, two membrane-bound (PVRa and PVR6) and two secreted (PVRT3 and PVRy) forms, have so far been identified and shown to be generated by alternative splicing from the primary transcript
MATERIALS AND METHODS
Production of Transgenic Mice. The human PVR gene has been cloned into cosmid vector pTL5 and designated HC3 and HC5 (5) . The cosmid clones were linearized by cutting at the unique Sal I site within the nucleotide sequence on the vector DNA. The linearized DNA was introduced into the pronuclei of ICR or C57BL/10 mouse zygotes as described by Brinster et al. (6) .
Southern and RNA Blot Hybridization. The genomic DNAs were prepared from HeLa S3 cells and the liver of the mice and were digested with BamHI or HindIll. Ten micrograms of the digests was separated by gel electrophoresis on 0.8% agarose and analyzed by Southern blot hybridization using standard procedures (7) . Messenger RNAs of cells or tissues were isolated by the cesium trifluoroacetate/guanidine thiocyanate method (8) . Two micrograms of poly(A)+ RNA purified by Oligotex-dT30 (Takara Shuzo, Kyoto) was analyzed by RNA (Northern) blot hybridization (7) .
An EcoRI/BamHI cDNA fragment (nucleotide positions 278-1227), indicated by a line with arrowheads in Fig. la Immunocytochemistry. The CNSs from the transgenic mice and normal mice inoculated intracerebrally with or without the Mahoney strain of poliovirus were fixed in 10%1 buffered formalin solution and embedded in paraffin. Thin sections (3-pum thickness), after deparaffinization, were treated with 0.25% trypsin for 2 hr and used for detection of viral antigens by the immunoperoxidase method (avidin-biotin complex, ABC). Hyperimmune anti-type 1 poliovirus rabbit serum was applied for the first overlay for 24 hr at 4°C. After washing, vectastain ABC kits (Vector Laboratories) were used for visualization. Since PVR mRNAs are detected also in the liver by PCR as described below, the level of the mRNA must be very low in the liver of the transgenic mice. Apparent density of bands is different in the tissues. These results strongly suggest that the amount of PVR mRNAs varies from tissue to tissue. Thus expression of the human PVR gene appears in many tissues of the transgenic mice as it does in human tissues (4, 5).
RESULTS

Transgenic
Since mRNAs for both membrane-bound (functional) and secreted forms of PVRs migrate in a gel at the same position, we used PCR to know the type of PVR mRNAs expressed in individual tissues (Fig. 2b) . Three bands corresponding to mRNA species for PVRa, PVRB, and PVRy were observed in PCR products from RNAs of all tissues tested as well as HeLa S3 cells (Fig. 2b, lane 1) . This observation is similar to that obtained with RNAs from human tissues (5). The results strongly suggest that a similar multiple splicing also occurs in many tissues of the transgenic mice as it does in those of humans and provides three different PVR mRNA isoforms in regard to the nucleotide sequences encoding the transmembrane domain. PVR6 mRNA was not detected in this experiment because of the primers used for the polymerization reactions.
Susceptibility to Poliovirus. Susceptibility of the transgenic mice to all three poliovirus serotypes was examined (Fig. 3  a-c) . The virulent poliovirus strains Mahoney, Lansing, and Leon were used as representatives of types 1, 2, and 3, respectively. The transgenic mice were inoculated intracerebrally with various doses of these virus strains and observed for paralysis or death. The results are shown in Fig.  3 a-c. Doses of 102_103 pfu of the virulent strains caused death of the transgenic mice. However, normal ICR mice did not show any clinical symptoms even if 108 pfu of the Mahoney or Leon strain was inoculated (data not shown). Normal mice showed susceptibility only to the Lansing strain as expected (Fig. 3e) (10) , although the level of the susceptibility was lower as compared with that of the transgenic mice. Thus, it is clear that the human PVR gene PVS confers the permissiveness for poliovirus to mice in vivo as well as mouse cells in vitro.
Inoculation of 107 pfu of the Mahoney strain with other routes such as intraperitoneal and subcutaneous routes also caused the same clinical symptoms and death as those with an intracerebral route. However, the transgenic mice orally administered with the Mahoney strain of up to 108 pfu did not show any clinical signs. Similar low rate of "virus take" from the alimentary canal is well known for cynomolgus monkeys that are highly sensitive to inoculation of poliovirus into the CNS.
Viral Multiplication Sites in the CNS. The main clinical sign observed in transgenic mice inoculated with poliovirus is flaccid paralysis of hindlimbs, which is similar to that of monkeys. This observation suggests that motor neurons in the spinal cord and nerve cells in the medulla oblongata are mainly damaged by the lytic virus infection. Accordingly, immunocytochemical analysis was performed on the CNS of the transgenic mice inoculated with the Mahoney strain intracerebrally (Fig. 4) . Poliovirus antigens were detected mainly in motor neurons in any transverse section of the lumbar, thoracic, and cervical cords, medulla oblongata, and pons but not in the cerebellum or in cerebrum of the CNS of the transgenic mice inoculated with the Mahoney strain. The stained transverse sections from the cervical (Fig. 4 a and b) and lumbar (Fig. 4 c and d ) cords are shown. However, transgenic mice without the virus infection and normal mice with the virus infection did not show any antigens or any lesions in the CNS (data not shown). These observations are very similar to the findings in humans who died of poliovirus infection at the acute stage and monkeys inoculated with the Mahoney strain into the spinal cord (data not shown). Thus, cell types sensitive to poliovirus infection in the CNS of the transgenic mice appear to be identical to those of humans and monkeys (11) . Poliovirus antigens were also detected in similar cell types in the CNS of normal mice inoculated with the Lansing strain (12) .
Neurovirulence of the Attenuated Strains. Neurovirulence of the live attenuated poliovirus vaccine strains was examined in the transgenic mice and compared with that of the virulent strains (Fig. 3) . A dose of 106 pfu of the Sabin 1 strain was required to cause paralysis and death in all of the transgenic mice, whereas 102 pfu of the Mahoney strain was enough to kill the mice (compare Fig. 3 a and d) . Furthermore, an average period of paralysis caused by the Sabin 1 strain was much longer than that by the Mahoney strain (Fig.  3 a and d) with each other (Table 1) . On day 7 after the inoculation, the transgenic mice inoculated with 103 pfu ofthe Mahoney strain or 106 pfu of the Sabin 1 strain showed paralysis. Viruses were recovered from the CNS of these mice and the amounts of viruses were measured. At the same time, normal ICR mice inoculated with 103 or 106 pfu of the Mahoney strain or 106 pfu of the Sabin 1 strain were sacrificed, and the amounts of viruses recovered from the CNSs were also measured.
As shown in Table 1 , the amounts ofboth the Mahoney and Sabin 1 strains dramatically decrease in the CNS of normal mice during the 7 days after the inoculation, although the amount of the Mahoney strain recovered is approximately 100-fold of that of the Sabin 1 strain, suggesting that the Mahoney strain is more stable than the Sabin 1 strain in the CNS ofthe mice. In the case ofthe transgenic mice, however, 1407 pfu of the virus was recovered from both the brain and (Table 1) . The data clearly indicate that the multiplication ability of the Sabin 1 strain in the CNS is much lower than that of the Mahoney strain. These results strongly suggest that the different mouse neurovirulence between the two strains is due to different efficiency in the viral multiplication in the CNS. Similar observations were reported for the CNS of monkeys (11) . Thus, the results of the mouse neurovirulence tests appear to reflect those ofmonkey neurovirulence tests, as suggested by mouse neurovirulence tests on mouse adapted chimera polioviruses that carry a part of the viral capsid polyprotein derived from the Lansing strain (13, 14) . DISCUSSION Poliovirus-sensitive transgenic mice were produced by introducing the human PVR gene into the mouse genome. Northern blot hybridization analysis and PCR experiments indicated that the human PVR gene introduced into the mouse genome transcribed in a number of tissues of the transgenic mice, and that the alternative splicing observed in human tissues also occurred in the mouse tissues. The observations suggest that the control mechanisms for the expression of the human PVR gene in the transgenic mice are the same as those in humans, although the expression of the PVR gene in individual cell types is not studied yet. Virus multiplication sites in the CNS of the transgenic mice appear to be identical to those in the CNSs of humans and monkeys. This result may indicate that the same control mechanisms for the human PVR gene expression exist at least in the CNSs of the transgenic mice and humans.
The reason why all of the human tissues in which the PVR gene is expressed are not the sites of poliovirus replication is not clear. It is possible that the functional PVRs are produced only in the limited cell types that contribute to the development of pathogenesis of the virus. For example, endothelial cells carrying PVR are proposed as the extraneural target cells that may have a role in the establishment of the persistent viremia (15) . Alternatively, other factors, in addition to PVR, may also have important roles to provide the permissiveness for poliovirus. Such a factor may be a 100-kDa polypeptide identified by Shepley et al. (16) . More studies may give an insight into the mechanisms for pathogenesis of poliovirus in humans if the control mechanisms for the human PVR gene expression in the transgenic mice are the same as those in humans.
The molecular mechanisms for the differential multiplication between the virulent and attenuated poliovirus strains are unknown at present. Monkey neurovirulence tests on a number of recombinant viruses between the virulent Mahoney and attenuated Sabin 1 strains have revealed that relatively strong determinant(s) influencing the neurovirulence or attenuation phenotype resided in the 5' noncoding region of the genome (9, 17, 18) . These observations suggest that cellular factor(s) supporting poliovirus replication by recognizing the structure of the 5' noncoding sequence of the genome is not sufficiently functional for the replication of the Sabin 1 strain in the CNS of monkeys. Although the mechanisms for the differential multiplication might not be the same in the CNSs of monkeys and the transgenic mice, it is of interest that the difference in multiplication of the virulent and attenuated poliovirus strains is similarly observed in the transgenic mice. It is possible therefore that the transgenic mice could become an animal model in place of monkeys to assess oral poliovirus vaccines.
Physiological function of the PVR molecules is unknown at present. The immunoglobulin superfamily is one of the important groups not only in immunity but also in the mediation of cell-surface recognition to control the behavior of cells in various tissues (19) . Elucidation of cell type-specific expression of the human PVR gene depending on a stage of differentiation of cells and tissues of the transgenic mice may give an insight into the physiological functions of the molecules.
